MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Why Tokenized Stocks Are Booming in 2026 While Crypto Is Still Struggling
From Pump.fun to Collector Crypt: Has Solana's income throne changed hands?
Looking at Stripe's ambitions and the future of stablecoins from OUSD
Do you want to buy CRCL?
Wosh: Inflation has cooled in recent weeks, AI is reshaping the economy, and forward guidance has lost its necessity
The most secretive AI winner
Former ByteDance employee's account: How I started with two Pinduoduo hard drives and made six times the profit with Seagate to achieve financial freedom?
MiCA reshuffle begins, Binance temporarily bids farewell to the EU
How does Gate redo "buying and selling stocks" from the cryptocurrency world to the stock market?
Visa and Mastercard join 140 giants to launch a new stablecoin, but the impact on the market landscape may still be limited
Circle CEO responds to OUSD's challenge: Stablecoins are a winner-takes-all business, and we will not slow down
Argentina vs Cape Verde: When a Record-Breaking Legend Meets an Unbreakable Underdog
WEEX exclusive pre-match analysis of Argentina vs Cape Verde, exploring Messi-led Argentina’s dominance and Cape Verde’s historic defensive breakout, with a breakdown of volatility, structure, and match dynamics.
